Press release
United States Novel Drug Delivery System Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
Novel Drug Delivery System Market
Global Novel Drug Delivery System Market reached US$ 12.6 billion in 2022 and is expected to reach US$ 55.7 billion by 2030, growing with a CAGR of 21.2% during the forecast period 2024-2031.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/novel-drug-delivery-system-market?sb
Key Development:
United States: Recent Novel Drug Delivery System Developments
✅ In February 2026, the FDA approved Eli Lilly's multi‐dose KwikPen version of its Zepbound weight‐loss therapy, introducing a four‐dose delivery device that enhances user convenience and treatment adherence for chronic weight management.
✅ In February 2026, the FDA published its list of novel drug approvals for 2026, highlighting multiple new therapeutics that may integrate advanced delivery strategies or dosing technologies as they progress toward commercialization.
✅ In January 2026, microneedle drug delivery systems attracted heightened industry focus with market forecasts and investment activity signaling acceleration in minimally invasive delivery platforms and hospital adoption trends.
✅ In December 2025, biotech fundraising rounds included capital boosts for companies advancing long‐acting treatment platforms, supporting investigational drug delivery innovations and extended‐release therapeutic technologies.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=novel-drug-delivery-system-market
Japan: Recent Novel Drug Delivery System Developments
✅ In February 2026, research on strategic body‐distribution control and targeted delivery enhancements for nucleic acid and mRNA medicines was featured in an industry webinar discussing advanced DDS technologies such as lipid nanoparticles and exosomes.
✅ In February 2026, the in situ gel drug delivery market in Japan was profiled in a detailed industry analysis report, highlighting technological advancements in thermoresponsive gels and minimally invasive drug administration techniques.
✅ In December 2025, a market intelligence report on connected drug delivery devices in Japan was published, outlining recent trends, demand drivers and innovation opportunities for integrated delivery solutions across therapeutic areas.
✅ In December 2025, the Japanese drug delivery devices market report noted continued progress in novel delivery technologies such as injectors, patches and implantables that enhance precision administration aligned with evolving healthcare needs.
Key Players:
=> Abbott Laboratories, Pfizer Inc, Johnson & Johnson Inc, F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Novartis AG, Baxter, Spectrum Pharmaceuticals Inc, Boston Scientific Corporation, and AstraZeneca PLC.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/novel-drug-delivery-system-market?sb
Key Segments:
By Route of Administration
Oral Drug Delivery Systems - 40%
Most widely adopted due to patient compliance, ease of administration, and cost-effectiveness.
Injectable Drug Delivery Systems - 30%
Preferred for high-potency biologics, vaccines, and critical care therapies.
Pulmonary Drug Delivery Systems - 10%
Used mainly for respiratory diseases and emerging inhalation therapies.
Transdermal Drug Delivery Systems - 15%
Growing due to convenience, controlled release, and non-invasive administration.
Others - 5%
Includes ocular, nasal, and buccal delivery systems.
By Mode
Targeted Drug Delivery Systems - 35%
High demand in oncology, autoimmune, and neurological disorders.
Controlled Drug Delivery Systems - 40%
Widely used for chronic diseases requiring sustained release (e.g., diabetes, cardiovascular diseases).
Modulated Drug Delivery Systems - 25%
Emerging applications in precision medicine and adaptive therapies.
By Indication
Oncology - 25%
Largest segment driven by targeted and controlled drug delivery therapies.
Infectious Diseases - 15%
Growth from vaccines, antivirals, and antibiotic-resistant infections.
Respiratory Diseases - 10%
Increasing due to pulmonary drug delivery systems for asthma, COPD, and COVID-19 therapeutics.
Diabetes - 12%
Demand for insulin and oral controlled-release therapies.
Cardiovascular Diseases - 10%
Driven by chronic therapies requiring controlled release.
Autoimmune Diseases - 8%
Therapies like biologics for RA, Crohn's disease, and lupus.
Neurological Disorders - 10%
Emerging segment for CNS-targeted therapies.
Others - 10%
Covers rare diseases, personalized medicine, and niche therapies.
By End-User
Hospitals - 35%
Primary users for injectable, targeted, and controlled delivery systems.
Specialty Clinics - 20%
Key for chronic disease management and outpatient therapy.
Ambulatory Surgery Centers - 15%
Use focused on perioperative drug administration and postoperative care.
Home Care Settings - 15%
Driven by oral, transdermal, and self-administered therapies.
Academic Research Institutes - 10%
R&D and early-stage drug delivery trials.
Others - 5%
Includes government healthcare programs, NGOs, and niche end-users.
By Region
North America - 35%
U.S. - 25%
Canada - 7%
Mexico - 3%
Europe - 25%
Germany - 6%
UK - 5%
France - 4%
Italy - 3%
Spain - 2%
Rest of Europe - 5%
South America - 8%
Brazil - 4%
Argentina - 2%
Rest of South America - 2%
Asia-Pacific - 25%
China - 10%
India - 5%
Japan - 5%
Australia - 2%
Rest of Asia-Pacific - 3%
Middle East & Africa - 7%
Driven by rising healthcare infrastructure and chronic disease prevalence.
Outlook & Opportunity Analysis (2024-2031)
The advanced drug delivery systems market is expected to grow robustly due to:
Rising demand for targeted and controlled drug delivery systems in oncology and chronic diseases.
Growth of home care and specialty clinics, boosting oral and transdermal delivery adoption.
Technological advancements in pulmonary and modulated drug delivery systems.
Expansion in Asia-Pacific and Middle East & Africa due to healthcare infrastructure investments.
FAQ
What is the current size of the Novel Drug Delivery System Market?
A: In 2022, the Novel Drug Delivery System Market was valued at US$ 12.6 billion, reflecting its strong industry presence.
Q2: How large is the Novel Drug Delivery System Market expected to be by 2030?
A: By 2030, industry forecasts suggest the Novel Drug Delivery System Market will grow to around US$ 55.7 billion , demonstrating significant expansion.
Q3: What is the growth rate of the Novel Drug Delivery System Market?
A: The market is projected to expand at a compound annual growth rate (CAGR) of 21.2% during the forecast period from 2024 to 2031.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Novel Drug Delivery System Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities here
News-ID: 4402968 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Intelligent Emergency Response Systems and Infrastructure Market Rises as AI Dis …
The global Intelligent Emergency Response Systems and Infrastructure (IRSI) market was valued at US$ 1.3 billion in 2022 and is projected to reach US$ 2.1 billion by 2031, growing at a CAGR of 6.1% during the forecast period from 2024 to 2031. Market growth is driven by increasing investments in smart public safety infrastructure, AI-powered emergency response systems, and the rising need for disaster preparedness and real-time incident management.The Intelligent…
Anti-Senescence Therapeutics Market Moves From Longevity Hype Toward Biomarker-L …
The global anti-senescence therapeutics market was valued at USD 33.03 billion in 2025 and is projected to reach USD 53.39 billion by 2033, growing at a CAGR of 6.7% during the forecast period from 2026 to 2033. Market growth is driven by increasing investments in longevity research, rising prevalence of age-related diseases, and advancements in regenerative medicine and senolytic therapies. The Anti-Senescence Therapeutics Market is entering a new phase of…
Molecular Biosensors Market Accelerates as Point-of-Care Testing Moves Toward Fa …
The global Molecular Biosensors Market was valued at USD 30.80 billion in 2024, increased to USD 33.55 billion in 2025, and is estimated to reach USD 36.55 billion in 2026. The market is projected to grow to USD 56.04 billion by 2031, registering a CAGR of 8.93% during the forecast period from 2026 to 2031. These advanced sensing technologies combine molecular recognition with highly sensitive detection systems, enabling clinicians to…
ECG Patches and Holter Monitor Market Expands as Remote Cardiac Monitoring Shift …
The Global ECG Patches and Holter Monitor Market reached US$ 1,864.54 million in 2024 and is projected to grow to US$ 5,950.62 million by 2033, expanding at a CAGR of 13.7% during the forecast period (2025-2033). This robust growth reflects the increasing shift from short-term, wearable monitoring solutions that enable earlier detection of arrhythmias and other heart rhythm disorders. Advances in wearable ECG patches, cloud-connected monitoring platforms, and AI-assisted…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
